Your browser doesn't support javascript.
loading
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML.
Zeidan, Amer M; Boss, Isaac; Beach, C L; Copeland, Wilbert B; Thompson, Ethan; Fox, Brian A; Hasle, Vanessa E; Hellmann, Andrzej; Taussig, David C; Tormo, Mar; Voso, Maria Teresa; Cavenagh, James; O'Connor, Tim; Previtali, Alessandro; Rose, Shelonitda; Silverman, Lewis R.
Afiliação
  • Zeidan AM; Yale University and Yale Cancer Center, New Haven, CT.
  • Boss I; Bristol Myers Squibb, Princeton, NJ.
  • Beach CL; Bristol Myers Squibb, Princeton, NJ.
  • Copeland WB; Bristol Myers Squibb, Princeton, NJ.
  • Thompson E; Bristol Myers Squibb, Princeton, NJ.
  • Fox BA; Bristol Myers Squibb, Princeton, NJ.
  • Hasle VE; Bristol Myers Squibb, Princeton, NJ.
  • Hellmann A; University Clinical Center of Medical University of Gdansk, Gdansk, Poland.
  • Taussig DC; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • Tormo M; Hospital Clinico Universitario de Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.
  • Voso MT; AF Oncoematologia-Universita' di Roma Tor Vergata, Rome, Italy.
  • Cavenagh J; Barts Health NHS Trust, St. Bartholomew's Hospital, West Smithfield, London, United Kingdom; and.
  • O'Connor T; Bristol Myers Squibb, Princeton, NJ.
  • Previtali A; Bristol Myers Squibb, Princeton, NJ.
  • Rose S; Bristol Myers Squibb, Princeton, NJ.
  • Silverman LR; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.
Blood Adv ; 6(7): 2219-2229, 2022 04 12.
Article em En | MEDLINE | ID: mdl-34933333

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article